Kalbe Genexine Biologics

Fineline Info & Tech (Flcube.com) provides you with comprehensive information about Kalbe Genexine Biologics, including details on the company, its pharmaceuticals, policies, deals, healthcare enterprises, research and development, hospitals, legal patents, and internet healthcare. More information about Kalbe Genexine Biologics please access flcube.com

Company Deals

Bio-Link Capital Completes Strategic Investment in TYK Medicines – Doubling Down on Bispecific, Trispecific and ADC Antibody Platforms

Bio-Link Capital announced the completion of a strategic investment in TYK Medicines (HKG: 2410), a macromolecule innovative drug company focused on the development of next‑generation antibody therapeutics, including bispecific antibodies,…

October 19, 2026

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

October 19, 2026

Brii Biosciences Launches BRiSC Bispecific siRNA Platform – Dual‑Target RNAi Engine to Advance Next‑Generation RNA Therapeutics in Prevalent Diseases

October 16, 2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.

Explore Now